All Columns articles – Page 7
-
OpinionNuclear wasted
Atomic energy has the potential to reduce our carbon footprint, but the problem of waste is devilishly complex
-
-
OpinionN-heterocyclic carbenes are more than passive spectators
The practical importance of N-heterocyclic carbenes continues to grow
-
OpinionTurning negative results into positives
Publishing unsuccessful experiments is more important than ever as we try to train machines in chemistry
-
CareersMore guidance makes job and university applications fairer
A question-based format helps candidates prioritise what to tell recruiters
-
OpinionA decade on Crispr is already poised to deliver on its promise
Gene editing could transform healthcare but no disease should be forgotten
-
OpinionHow long until papers list an AI as an author?
Artificial intelligence is superior to humans at numerous tasks, but it is still vulnerable to human biases
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
-
OpinionWill we always keep naming things after people?
Choosing a name deserves careful consideration
-
OpinionEmbracing oddities
When new chemistry looks like alchemy or witchcraft, it’s worth taking notice
-
OpinionWe’re all in this together
As rivalry between countries increases scientific collaboration must be maintained to tackle our shared problems
-
OpinionElizabeth Holmes to be imprisoned for Theranos fraud
Blood testing company founder’s 11-year sentence should serve as a warning to investors
-
OpinionThe incredible legacy of Tutankhamun
Three-thousand-year-old treasures can still enthral and inspire
-
OpinionWhy glycans?
Glycoscience is turning out to be more interesting than anyone might have imagined
-
OpinionTrouble at the top of the UK government spells trouble for science too
Science craves certainty but the UK hasn’t been able to deliver it recently
-
OpinionTwelve reasons for labs to go greener
How your lab can benefit from cutting energy, water and waste
-
OpinionNobel vision
Looking beyond the here-and-now let click chemistry open up a whole new world of possibility
-
BusinessAlzheimer’s antibody engenders anticipation
Tantalising press-released data on Biogen and Eisai’s lecanemab prompt questions without firm answers
-
OpinionKnocking down paywalls
President Biden’s surprise announcement ending paywalls for federally-funded research by 2026 has left publishers scrambling to respond